U.S. proposes Medicare, Medicaid programs to cut drug costs, including $2 generics

United States News News

U.S. proposes Medicare, Medicaid programs to cut drug costs, including $2 generics
United States Latest News,United States Headlines
  • 📰 Reuters
  • ⏱ Reading Time:
  • 55 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 25%
  • Publisher: 97%

The U.S. health department proposed on Tuesday three new pilot projects aimed at lowering prescription drug prices for people enrolled in government health insurance plans, including offering some essential generic drugs for $2 a month.

The second voluntary model allows state Medicaid agencies to pay for cell and gene therapies by delegating authority to CMS so it can facilitate contracts and payment models as well as structure and coordinate multi-state arrangements with manufacturers.

The agency also said it would work on developing a mandatory model for payment methods for drugs approved by the U.S. Food and Drug Administration under its Accelerated Approval Program . CMS has raised concerns about covering drugs under the pathway such as those for Alzheimer's disease because it does not require the same degree of drug efficacy data as the FDA's regular approval process.

The model would address the high cost and lack of confirmed effectiveness of drugs that receive accelerated approval through providing drugmakers with incentives to speed up the completion of confirmatory clinical trials, CMS said, and would be developed in consultation with the FDA. CMS will announce the first model's start date "as soon as operationally feasible", it said. Development on the Medicaid gene and cell therapy model will start in 2023 and launch for testing in 2026. The agency will start working with the FDA on the accelerated approval model in 2023 but has no planned launched date yet.Ahmed AbouleneinWashington-based correspondent covering U.S.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

Reuters /  🏆 2. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

In Tennessee, a Medicaid mix-up could land you on a 'most wanted' listIn Tennessee, a Medicaid mix-up could land you on a 'most wanted' listMedicaid enrollment swelled during the pandemic. And some states are being especially aggressive at policing their rolls.
Read more »

How vulnerable is Medicaid in the debt ceiling battle?How vulnerable is Medicaid in the debt ceiling battle?
Read more »

Biden administration allows Medicaid funds to be used to pay for groceries and rentBiden administration allows Medicaid funds to be used to pay for groceries and rentSeveral states are using the Medicaid program as a tool to address food insecurity with the approval of the Biden administration, directing funding to pay for groceries and offer nutritional counseling.
Read more »

Biden escalates fight over Social Security and Medicare, frustrating RepublicansBiden escalates fight over Social Security and Medicare, frustrating RepublicansAfter President Biden pummeled Republicans on Social Security and Medicare during his State of the Union address, Republican leaders urged him to stop telling Americans that the GOP wants to slash those retirement programs.
Read more »

Biden escalates fight over Social Security and Medicare, frustrating RepublicansBiden escalates fight over Social Security and Medicare, frustrating RepublicansWASHINGTON — After President Joe Biden pummeled Republicans on Social Security and Medicare during his State of the Union address, drawing shouts of outrage from the party, Republican leaders urged him to stop telling Americans that the GOP wants to slash those retirement programs.
Read more »

Workplace plans paid more than Medicare for physician-administered drugs, study findsWorkplace plans paid more than Medicare for physician-administered drugs, study findsEmployer-sponsored health plans pay significantly more than Medicare for costly physician-administered drugs, threatening access to lifesaving treatments, according to a newly published analysis.
Read more »



Render Time: 2025-03-10 07:05:19